Chronic subcutaneous brain natriuretic peptide therapy in asymptomatic systolic heart failure-Reference-Cited by-同舟云学术

Chronic subcutaneous brain natriuretic peptide therapy in asymptomatic systolic heart failure

Published:2016-01-24 Issue:4 Volume:18 Page:433-441
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:Eur J Heart Fail

Author:

McKie Paul M.¹,Schirger John A.¹,Benike Sherry L.¹,Harstad Lynn K.¹,Slusser Joshua P.²,Hodge David O.²,Redfield Margaret M.¹,Burnett John C.¹,Chen Horng H.¹

Affiliation:

1. Cardiorenal Research Laboratory, Division of Cardiovascular Diseases; Mayo Clinic and Foundation; Rochester MN USA

2. Division of Biomedical Statistics and Informatics; Mayo Clinic and Foundation; Rochester MN USA

Funder

National Institutes of Health

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ejhf.468/fullpdf

Reference40 articles.

1. 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation;Jessup;Circulation,2009

2. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines;Yancy;J Am Coll Cardiol,2013

3. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic;Redfield;JAMA,2003

4. Natural history of asymptomatic left ventricular systolic dysfunction in the community;Wang;Circulation,2003

5. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC;McMurray;Eur J Heart Fail,2012

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. B-Type Natriuretic Peptide Inhibits the Expression and Function of SERCA2a in Heart Failure;International Heart Journal;2024-03-30

2. An Hypothesis: Disproportion Between Cardiac Troponin and B-Type Natriuretic Peptide Levels—A High Risk and Poor Prognostic Biomarker in Patients With Fulminant Myocarditis?;Heart, Lung and Circulation;2021-06

3. STOP-HF Trial;JACC: Basic to Translational Science;2021-06

4. Therapeutic effects of recombinant human brain natriuretic peptide on sepsis-associated encephalopathy in mice;International Immunopharmacology;2020-04

5. B-type natriuretic peptide and its role in altering Ca2+-regulatory proteins in heart failure—mechanistic insights;Heart Failure Reviews;2019-12-09